Affiliation: Cleveland Clinic Foundation
- Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary studyMariusz Kruk
New York University School of Medicine, New York, New York, USA
BMC Cardiovasc Disord 13:91. 2013....
- Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])Venu Menon
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
Am J Cardiol 111:930-5. 2013..Consistent with the overall trial results, stable patients with NSTEMI and a totally occluded IRA did not benefit from randomization to percutaneous coronary intervention...
- Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromesVenu Menon
Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am J Med 119:584-90. 2006..An analysis of reginal variation across the United States in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) has not been previously performed...
- Optimal management of acute aortic dissectionVenu Menon
Venu Menon, MD Division of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Curr Treat Options Cardiovasc Med 11:146-55. 2009....
- Incremental prognostic value of diastolic dysfunction in low risk patients undergoing echocardiography: beyond Framingham scoreWael A AlJaroudi
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA
Int J Cardiovasc Imaging 29:1441-50. 2013..6 [1.25; 5.55], p = 0.01). In low-risk adult outpatients undergoing echocardiography, DD was associated with 2-3 fold increase in risk of death and had incremental prognostic value beyond FRS...
- Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrestThomas J Helton
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Catheter Cardiovasc Interv 80:E9-14. 2012....
- Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shockMatthew A Cavender
Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
J Invasive Cardiol 25:218-24. 2013....
- Options for managing severe aortic stenosis: a case-based reviewOlcay Aksoy
Department of CardiovascularMedicine, Cleveland Clinic, Cleveland, OH 44195, USA
Cleve Clin J Med 80:243-52. 2013..In this article, we use clinical vignettes to illustrate the management of patients with severe aortic stenosis...
- Transfer of patients with suspected acute aortic syndromeBhuvnesh Aggarwal
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
Am J Cardiol 112:430-5. 2013....
- Do bisphosphonates slow the progression of aortic stenosis?Olcay Aksoy
Department of Cardiovascular Medicine, Cleveland Clinic, Ohio 44195, USA
J Am Coll Cardiol 59:1452-9. 2012..The aim of this study was to investigate the impact of bisphosphonates on the progression of aortic stenosis...
- Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathyWael Aljaroudi
Section of Cardiovascular Imaging, Division of Cardiovascular Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J1 5, Cleveland, OH 44195, USA
J Nucl Cardiol 19:958-69. 2012....
- Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump supportOlcay Aksoy
Department of Cardiovascu Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Heart 97:838-43. 2011..To investigate the haemodynamic effects of intra-aortic balloon pump (IABP) support in patients with severe aortic stenosis (AS) presenting in cardiogenic shock (CS)...
- Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary interventionDharam J Kumbhani
Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
Am J Cardiol 109:1087-91. 2012..007). In conclusion, although overall mortality rates are similar between men and women undergoing PCI for NSTE-ACS, women <60 years old with negative biomarkers have a higher mortality than their men peers...
- Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysisShikhar Agarwal
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio, USA
Arch Intern Med 172:623-31; discussion 631-3. 2012..We performed a meta-analysis of safety and efficacy outcomes in patients with AF treated with warfarin for stroke prevention in large contemporary randomized controlled trials (RCTs)...
- Dynamic outflow tract obstruction in congenitally corrected transposition of the great arteriesAndrew O Zurick
Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Desk J1 5, Cleveland, OH 44195, USA
Int J Cardiovasc Imaging 26:617-9. 2010..Ultimately, our patient was felt to be too high-risk for surgical correction and a course of medical therapy has been pursued...
- Prognostic implications of pulmonary hypertension in patients with severe aortic stenosisAkin Cam
Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA
J Thorac Cardiovasc Surg 142:800-8. 2011....
- Dual antiplatelet therapy in coronary artery disease: a case-based approachChad Raymond
Internal Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Cleve Clin J Med 76:663-70. 2009..The guidelines are based on strong evidence from several large randomized clinical trials over the last 10 years. The authors present several cases to show how to put this evidence into day-to-day clinical practice...
- Magnitude and consequences of missing the acute infarct-related circumflex arteryAmar Krishnaswamy
Cleveland Clinic Division of Cardiovascular Medicine, OH 44195, USA
Am Heart J 158:706-12. 2009..Heightened awareness of this clinical scenario and the available methods to avoid missing this elusive diagnosis are imperative in our quest to further improve the outcomes of patients with acute myocardial infarction...
- Measuring and treating serum lipids in patients in a chest pain observation unitMichael J Gillespie
Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, and The Cleveland Clinic, OH, USA
Am J Cardiol 99:1718-20. 2007..In addition to their primary role, CPOUs should focus on primary prevention and reduction of long-term risk...
- Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery TrialVenu Menon
Division of Cardiology, F 15, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH 4419, USA
Eur Heart J 30:183-91. 2009..We evaluated the potential for selective benefit with PCI over MED for patients enrolled early in OAT...
- Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shockShun Kohsaka
Department of Cardiology, Texas Heart Institute at St Luke s Episcopal Hospital and Baylor College of Medicine, Houston, USA
Arch Intern Med 165:1643-50. 2005....
- Burden of cardiovascular disease in chronic obstructive pulmonary diseaseShikhar Agarwal
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Am J Prev Med 47:105-14. 2014..Chronic obstructive pulmonary disease (COPD) and atherosclerotic vascular disease share several etiopathogenic factors...
- Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandateShikhar Agarwal
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk J 3 5, Cleveland, OH, 44195, USA
Am J Cardiovasc Drugs 14:191-207. 2014..We aimed to perform an updated meta-analysis of randomized controlled trials (RCTs) to investigate the differences in cardiovascular death, myocardial infarction (MI), and stroke between DPPI and placebo/alternative agents...
- Ranolazine: clinical applications and therapeutic basisNael Hawwa
Internal Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Am J Cardiovasc Drugs 13:5-16. 2013..In this article we present the experimental and clinical data that support its current therapeutic role, and provide insight into potential future clinical applications...
- Utility of a novel watch-based pulse detection system to detect pulselessness in human subjectsJohn Rickard
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
Heart Rhythm 8:1895-9. 2011..The Wriskwatch is a novel, watch-based pulse detection device that detects the loss of a radial pulse via advanced pulse detection technology and immediately contacts emergency medical systems...
- Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patientsDeborah H Kwon
Cleveland Clinic Foundation, 9500 Euclid Ave J1 5, Cleveland, Ohio 44195, USA
J Nucl Cardiol 17:853-7. 2010..Furthermore, low-level treadmill testing in a large population with regadenoson has not previously been evaluated. We describe our experience in the first 6 months of routine inpatient and outpatient clinical use...
- Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromesMonvadi B Srichai
Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am Heart J 147:84-90. 2004....
- Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trialStephen Gimple
Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
J Cardiovasc Nurs 23:30-3. 2008..No significant interaction between treatment effect and prespecified subgroups was observed. This lack of clinical benefit supports optimal medical therapy alone for Occluded Artery Trial-eligible patients in current clinical practice...
- Images in cardiovascular medicine. Acute myocardial infarction in uncorrected tetralogy of fallotEugene Shteerman
Division of Cardiology, St Lukes Roosevelt Hospital Center, New York, NY 10025, USA
Circulation 106:e13-4. 2002
- Management of cardiogenic shock complicating acute myocardial infarctionVenu Menon
Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, USA
Heart 88:531-7. 2002
- Cardiogenic shock: have we really found the magic potion?Venu Menon
Eur Heart J 24:1279-81. 2003
- The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee
St Luke s Roosevelt Hospital Center, Columbia University, NY 10025, USA
J Thromb Thrombolysis 14:91-101. 2002..A large trial of thrombolysis for acute myocardial infarction has reported an association between longer aPTTs and adverse outcomes...
- Establishing a new target range for unfractionated heparin for acute coronary syndromesMichael S Lee
St Luke s Roosevelt Hospital Center, Division of Cardiology, College of Physicians and Surgeons, Columbia University, 1111 Amsterdam Avenue, New York City, NY 10025, USA
J Thromb Thrombolysis 17:121-6. 2004....
- Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registryRupert Fincke
New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
J Am Coll Cardiol 44:340-8. 2004..We sought to analyze clinical, angiographic, and outcome correlates of hemodynamic parameters in cardiogenic shock...
- Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyVenu Menon
Division of Cardiology, University of North Carolina at Chapel Hill, 27599, USA
Chest 126:549S-575S. 2004....
- Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patternsJames W Hoekstra
Department of Emergency Medicine, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC 27157, USA
Acad Emerg Med 12:431-8. 2005....
- Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trialsMauricio G Cohen
Division of Cardiology, University of North Carolina at Chapel Hill, 130 Mason Farm Road, CB 7075, Bioinformatics Building Suite 4128, Chapel Hill, NC 27599, USA
Am J Med 118:482-8. 2005..To correlate pulmonary artery catheterization (PAC) use and 30-day outcomes and to characterize the use of pulmonary artery catheters among patients with acute coronary syndromes (ACS)...
- Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergenVladimir Dzavik
Interventional Cardiology Program, University Health Network, and University of Toronto, Toronto, Ontario, Canada
Am Heart J 149:1128-34. 2005..We sought to determine the reason for this finding by examining the baseline characteristics and outcomes of the 2 treatment groups by age...
- Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early impMauricio G Cohen
Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7075, USA
Am Heart J 152:110-7. 2006..Data regarding the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) in Hispanic patients, the largest and fastest-growing minority in the United States, are scarce...
- Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndromeJatin Joshi
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
Am J Cardiol 98:338-40. 2006....
- Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson
TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and the Department of Medicine, Harvard Medical School, Boston, MA, USA
Am Heart J 152:668-75. 2006..Early restoration of epicardial flow before primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has been associated with improved clinical outcomes...
- Outcome after surgery and percutaneous intervention for cardiogenic shock and left main diseaseMichael S Lee
Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
Ann Thorac Surg 86:29-34. 2008..The ideal revascularization strategy (bypass surgery versus percutaneous coronary intervention [PCI]) for patients with cardiogenic shock in the setting of left main coronary artery disease is unknown...
- Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Shaun G Goodman
St Michael s Hospital, Division of Cardiology, 30 Bond Street, Queen, Toronto, Ontario, Canada
Chest 133:708S-775S. 2008....